These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 25028484)

  • 1. A mouse model of human congenital heart disease: high incidence of diverse cardiac anomalies and ventricular noncompaction produced by heterozygous Nkx2-5 homeodomain missense mutation.
    Ashraf H; Pradhan L; Chang EI; Terada R; Ryan NJ; Briggs LE; Chowdhury R; Zárate MA; Sugi Y; Nam HJ; Benson DW; Anderson RH; Kasahara H
    Circ Cardiovasc Genet; 2014 Aug; 7(4):423-433. PubMed ID: 25028484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse Model of Human Congenital Heart Disease: Progressive Atrioventricular Block Induced by a Heterozygous Nkx2-5 Homeodomain Missense Mutation.
    Chowdhury R; Ashraf H; Melanson M; Tanada Y; Nguyen M; Silberbach M; Wakimoto H; Benson DW; Anderson RH; Kasahara H
    Circ Arrhythm Electrophysiol; 2015 Oct; 8(5):1255-64. PubMed ID: 26226998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical analyses of eight NKX2.5 homeodomain missense mutations causing atrioventricular block and cardiac anomalies.
    Kasahara H; Benson DW
    Cardiovasc Res; 2004 Oct; 64(1):40-51. PubMed ID: 15364612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of genetic modifiers ensures normal cardiac development.
    Winston JB; Erlich JM; Green CA; Aluko A; Kaiser KA; Takematsu M; Barlow RS; Sureka AO; LaPage MJ; Janss LL; Jay PY
    Circulation; 2010 Mar; 121(11):1313-21. PubMed ID: 20212279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways.
    Benson DW; Silberbach GM; Kavanaugh-McHugh A; Cottrill C; Zhang Y; Riggs S; Smalls O; Johnson MC; Watson MS; Seidman JG; Seidman CE; Plowden J; Kugler JD
    J Clin Invest; 1999 Dec; 104(11):1567-73. PubMed ID: 10587520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac septal and valvular dysmorphogenesis in mice heterozygous for mutations in the homeobox gene Nkx2-5.
    Biben C; Weber R; Kesteven S; Stanley E; McDonald L; Elliott DA; Barnett L; Köentgen F; Robb L; Feneley M; Harvey RP
    Circ Res; 2000 Nov; 87(10):888-95. PubMed ID: 11073884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NKX2.5 mutations in patients with congenital heart disease.
    McElhinney DB; Geiger E; Blinder J; Benson DW; Goldmuntz E
    J Am Coll Cardiol; 2003 Nov; 42(9):1650-5. PubMed ID: 14607454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analyses of GATA4, NKX2.5, and TFAP2B genes in subjects from southern China with sporadic congenital heart disease.
    Xiong F; Li Q; Zhang C; Chen Y; Li P; Wei X; Li Q; Zhou W; Li L; Shang X; Xu X
    Cardiovasc Pathol; 2013; 22(2):141-5. PubMed ID: 22959235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational spectrum in the cardiac transcription factor gene NKX2.5 (CSX) associated with congenital heart disease.
    Stallmeyer B; Fenge H; Nowak-Göttl U; Schulze-Bahr E
    Clin Genet; 2010 Dec; 78(6):533-40. PubMed ID: 20456451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel NKX2-5 mutations responsible for congenital heart disease.
    Wang J; Liu XY; Yang YQ
    Genet Mol Res; 2011 Nov; 10(4):2905-15. PubMed ID: 22179962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel point mutation in the cardiac transcription factor CSX/NKX2.5 associated with congenital heart disease.
    Ikeda Y; Hiroi Y; Hosoda T; Utsunomiya T; Matsuo S; Ito T; Inoue J; Sumiyoshi T; Takano H; Nagai R; Komuro I
    Circ J; 2002 Jun; 66(6):561-3. PubMed ID: 12074273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel NKX2-5 mutations in diseased heart tissues of patients with cardiac malformations.
    Reamon-Buettner SM; Hecker H; Spanel-Borowski K; Craatz S; Kuenzel E; Borlak J
    Am J Pathol; 2004 Jun; 164(6):2117-25. PubMed ID: 15161646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ablation of Nkx2-5 at mid-embryonic stage results in premature lethality and cardiac malformation.
    Terada R; Warren S; Lu JT; Chien KR; Wessels A; Kasahara H
    Cardiovasc Res; 2011 Jul; 91(2):289-99. PubMed ID: 21285290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A tyrosine-rich domain within homeodomain transcription factor Nkx2-5 is an essential element in the early cardiac transcriptional regulatory machinery.
    Elliott DA; Solloway MJ; Wise N; Biben C; Costa MW; Furtado MB; Lange M; Dunwoodie S; Harvey RP
    Development; 2006 Apr; 133(7):1311-22. PubMed ID: 16510504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. R25C mutation in the NKX2.5 gene in Italian patients affected with non-syndromic and syndromic congenital heart disease.
    Beffagna G; Cecchetto A; Dal Bianco L; Lorenzon A; Angelini A; Padalino M; Vida V; Bhattacharya S; Stellin G; Rampazzo A; Daliento L
    J Cardiovasc Med (Hagerstown); 2013 Aug; 14(8):582-6. PubMed ID: 22964646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive AV-block and anomalous venous return among cardiac anomalies associated with two novel missense mutations in the CSX/NKX2-5 gene.
    Gutierrez-Roelens I; Sluysmans T; Gewillig M; Devriendt K; Vikkula M
    Hum Mutat; 2002 Jul; 20(1):75-6. PubMed ID: 12112663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterization of a novel mutation in NKX2-5 associated with congenital heart disease and adult-onset cardiomyopathy.
    Costa MW; Guo G; Wolstein O; Vale M; Castro ML; Wang L; Otway R; Riek P; Cochrane N; Furtado M; Semsarian C; Weintraub RG; Yeoh T; Hayward C; Keogh A; Macdonald P; Feneley M; Graham RM; Seidman JG; Seidman CE; Rosenthal N; Fatkin D; Harvey RP
    Circ Cardiovasc Genet; 2013 Jun; 6(3):238-47. PubMed ID: 23661673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive atrioventricular conduction defects and heart failure in mice expressing a mutant Csx/Nkx2.5 homeoprotein.
    Kasahara H; Wakimoto H; Liu M; Maguire CT; Converso KL; Shioi T; Huang WY; Manning WJ; Paul D; Lawitts J; Berul CI; Izumo S
    J Clin Invest; 2001 Jul; 108(2):189-201. PubMed ID: 11457872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional defect of an inherited NKX2-5 haplotype comprising a SNP, a nonsynonymous and a synonymous mutation, associated with human congenital heart disease.
    Reamon-Buettner SM; Sattlegger E; Ciribilli Y; Inga A; Wessel A; Borlak J
    PLoS One; 2013; 8(12):e83295. PubMed ID: 24376681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital heart defect causing mutation in Nkx2.5 displays in vivo functional deficit.
    Zakariyah AF; Rajgara RF; Veinot JP; Skerjanc IS; Burgon PG
    J Mol Cell Cardiol; 2017 Apr; 105():89-98. PubMed ID: 28302382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.